20385 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom; Non condensed pyridines; Hydrogenated derivatives thereof; Non condensed piperidines, e.g. piperocaine Piperidinium derivatives
NITROXYL POLYPHENOL DERIVATIVE, METHODS FOR THE PREPARATION THEREOF AND USE THEREOF
#2Compositions and Methods for Treatment of Inflammatory Bowel Disease
#3HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#4DEGRADING PKCB1 TO TREAT CANCER
#5PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC AND POSTMENOPAUSAL OSTEOPOROSIS, CONTAINING ADIPORON
#6TREATMENT OF ER-NEGATIVE BREAST CANCER WITH AN PDGF-CC INHIBITOR AND AN ANTI-ESTROGEN
#7ANTIVIRAL COMPOSITION OBTAINED THROUGH DRUG REPOSITIONING
#8ANATABINE POWDER COMPOSITIONS
#9HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#10Glycine receptor modulators and methods of use
#11BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
#12Compounds for use in treating depression and migraine
#135-HT2A agonists for use in treatment of depression
#14CHARGED ION CHANNEL BLOCKERS AND METHODS FOR USE
#15TREATMENT OF CANCER USING A CEA CD3 BISPECIFIC ANTIBODY AND A WNT SIGNALING INHIBITOR
#16FORMULATIONS, METHODS, KIT, AND DOSAGE FORMS FOR IMPROVED STABILITY OF AN ACTIVE PHARMACEUTICAL INGREDIENT
#17NICOTINIC ACETYLCHOLINE RECEPTOR SILENT AGONISTS
#185-HTagonists for use in treatment of depression
#19COMPOSITIONS FOR TREATING MELANOMA
#20Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen
#21USE OF OPIOID ANTAGONISTS
#225-HTagonists for use in treatment of depression
#23HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#24Small molecule drugs and related methods for treatment of diseases related to TDP-43, alpha-synuclein, huntingtin's protein and tau protein oligomer formation
#25Compounds for use in treating depression and migraine
#26Charged ion channel blockers and methods for use
#27Nicotinic acetylcholine receptor silent agonists
#28Glycine receptor modulators and methods of use
#29TERTIARY AMINE COMPOUND OR IMINE COMPOUND-POLYMER CONJUGATE AND PRODUCTION METHOD THEREFOR
#30CRMP2 sumoylation inhibitors and uses thereof
#31IRE-1α inhibitors
#32Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#33HETEROCYCLIC COMPOUNDS USEFUL AS PDK1 INHIBITORS
#34Heterocyclic compound
#35Nicotinic acetylcholine receptor silent agonists
#36CRMP2 SUMOylation inhibitors and uses thereof
#37Charged ion channel blockers and methods for use
#38IRE-1α inhibitors
#39Heterocyclic compound
#40Enhanced ATRA-related compounds for the treatment of proliferative diseases, autoimmune diseases, and addiction conditions
#41USE OF OPIOID ANTAGONISTS
#42IRE-1α inhibitors
#43Modulators of 14-3-3 functionality and uses thereof
#44Compounds and methods for inhibiting production of trimethylamine
#45Aminoester derivatives
#46Heterocyclic compounds useful as PDK1 inhibitors
#47Compounds suitable for the treatment of myeloproliferative neoplasms as well as methods for the diagnosis/prognosis of myeloproliferative neoplasms
#48Bile acid recycling inhibitors for treatment of obesity and diabetes
#49Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof
#50Benzyl urea derivatives for activating TGF-beta signaling
#51Methods, compounds, and compositions for inhibition of ROS
#52Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
#53Agent for ameliorating chronic obstructive pulmonary disease
#54Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof
#55IRE-1α inhibitors
#56Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#57Agent for Ameliorating Chronic Obstructive Pulmonary Disease
#58Spirothienopyran-piperidine derivatives as ORL-1 receptor antagonists for their use in the treatment of alcohol dependence and abuse
#59BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF BARRETT'S ESOPHAGUS AND GASTROESOPHAGEAL REFLUX DISEASE
#60Biphenyl derivatives
#61Use of aminoindane compounds in treating overactive bladder and interstitial cystitis
#62Use of opioid antagonists
#63Oxidosqualene cyclase as a protein target for anticancer therapeutics
#64IRE-1α inhibitors
#65Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
#66NOVEL METHOD OF TREATMENT
#67Aminoindane compounds and use thereof in treating pain
#68Heterocyclic compounds useful as PDK1 inhibitors
#69BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF OBESITY AND DIABETES
#70Methods useful in the treatment of bone resorption diseases
#71Biphenyl derivatives
#72BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS
#73Quaternary ammonium salt prodrugs
#74Compositions Comprising N-Halogenated or N,N-Dihalogenated Amine for Treatment and Prophylaxis of Bronchopulmonary Infections
#75COMPOUNDS FOR THE TREATMENT OF PERIPHERAL NEUROPATHIES
#76Methods useful in the treatment of bone resorption diseases
#77METHODS OF TREATING POXVIRAL INFECTIONS
#78Use of opioid antagonists
#79(THIO) -CARBAMOYL-CYCLOHEXANE DERIVATIVES AND METHOD FOR TREATING SCHIZOPHRENIA
#80Bile acid recycling inhibitors for treatment of obesity and diabetes
#81Method of Treating Fibromyalgia or Associated Functional Symptoms of Fibromyalgia
#82Agents and crystals for improving excretory potency of urinary bladder
#83COMPOSITIONS FOR SLEEPING DISORDERS
#84Methods useful in the treatment of bone resorption diseases
#85M3 MUSCARINIC RECEPTOR ANTAGONISTS FOR TREATMENT OF M3 MUSCARINIC RECEPTOR-EXPRESSING TUMORS
#86Use of Antagonist of Oxytocin and/or Vasopressin in Assisted Reproduction
#87Use of Par-1/Par-4 Inhibitors for Treating or Preventing Vascular Diseases
#88Pharmaceutical uses
#89Stable gabapentin compositions
#90Small molecule inhibitors targeted at Bcl-2
#91Biphenyl derivatives
#92Biphenyl derivatives
#93PI3K-Akt Pathway Inhibitors
#94Biphenyl derivatives
#95Antiparasitic artemisinin derivatives (endoperoxides)
#963,4,5-Substituted piperidines as therapeutic compounds
#97Pharmaceutical uses
#98Agents For Treating Neurodegenerative Diseases
#99Biphenyl derivatives
#100Agents for treating neurodegenerative diseases
#101Method of Modulating Apoptosis Through Modulation of E2F1
#102Biphenyl derivatives
#103Migrastatin analogs and uses thereof
#104Antiparasitic artemisinin derivatives (endoperoxides)
#105Salmeterol and ciclesonide combination
#106Method for treating glaucoma III B
#107Antiparasitic artemisinin derivatives (endoperoxides)
#108Agents and crystals for improving excretory potency of urinary bladder
#109Beta-blockers having antioxidant and no-donor activity
#110Biphenyl derivatives
#111Biphenyl derivatives
#112Biphenyl derivatives
#113Biphenyl derivatives
#114Methods useful in the treatment of bone resorption diseases
#115Reduction of hair growth
#116Methods for treating diabetes
#117Combination treatment for impaired motor function in parkinson's disease
#118Liquid paroxetine compositions
#119Immunodulatory compositions and methods of use thereof
#120Compositions for sleeping disorders
#121Doxepin analogs and methods of use thereof
#122Methods of treating sleep disorders
#123Doxepin analogs and methods of use thereof
#124Preventives for hiv infection
#125Methods of indirectly stimulating the vagus nerve with an electrical field
#126Doxepin analogs and methods of use thereof
#127Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome